{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:09:31Z","timestamp":1763078971646,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clim.2024.110372","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:26:06Z","timestamp":1727717166000},"page":"110372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Anti-interferon gamma-inducible protein 16 antibodies: Identification of a novel autoantigen in idiopathic interstitial pneumonia and its clinical characteristics based on a multicenter cohort study"],"prefix":"10.1016","volume":"268","author":[{"given":"Tsuneo","family":"Sasai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Tachikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Tomii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminobu","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Kogame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirei","family":"Shirakashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Akizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneyo","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.110372_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American thoracic society\/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias","volume":"165","author":"American Thoracic Society, European Respiratory Society, American thoracic S, European respiratory S","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110372_bb0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"ATS\/ERS Committee on idiopathic interstitial pneumonias, an official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110372_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110372_bb0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.resinv.2018.03.003","article-title":"Ministry of Health, Labour and Welfare, the study group on diffuse pulmonary disorders, scientific research\/research on intractable diseases, and Japanese respiratory society, Japanese guideline for the treatment of idiopathic pulmonary fibrosis","volume":"56","author":"Homma","year":"2018","journal-title":"Respir. Investig."},{"key":"10.1016\/j.clim.2024.110372_bb0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110372_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094775","article-title":"Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis","volume":"9","author":"Kono","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110372_bb0035","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110372_bb0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.002","article-title":"Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study","volume":"123","author":"Ji","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.clim.2024.110372_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/resp.13665","article-title":"Long-term clinical course and outcome of interstitial pneumonia with autoimmune features","volume":"25","author":"Kim","year":"2020","journal-title":"Respirology."},{"key":"10.1016\/j.clim.2024.110372_bb0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"\u201cERS\/ATS task force on undifferentiated forms of CTD-ILD\u201d, an official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2024.110372_bb0055","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01205-2020","article-title":"Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype","author":"Graham","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2024.110372_bb0060","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1038\/jid.1993.34","article-title":"Humoral immunity in polymyositis\/dermatomyositis","volume":"100","author":"Targoff","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110372_bb0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2397198320902667","article-title":"Antisynthetase syndrome: a distinct disease spectrum","volume":"5","author":"Huang","year":"2020","journal-title":"J. Scleroderma Relat. Disord."},{"key":"10.1016\/j.clim.2024.110372_bb0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"ATS\/ERS\/JRS\/ALAT committee on idiopathic pulmonary fibrosis, an official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110372_bb0075","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"American Thoracic Society, European Respiratory Society, Japanese respiratory society, and Latin American Thoracic Society, diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110372_bb0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1183\/09031936.00017711","article-title":"Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011","volume":"37","author":"Raghu","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2024.110372_bb0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1183\/09031936.00165111","article-title":"Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes","volume":"40","author":"Reddy","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2024.110372_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110372_bb0095","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/S0021-9258(17)35929-X","article-title":"Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders","volume":"261","author":"Mimori","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110372_bb0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/gtc.12832","article-title":"Identification and characterization of the antigen recognized by the germ cell mAb TRA98 using a human comprehensive wet protein array","volume":"26","author":"Fukuda","year":"2021","journal-title":"Genes Cells"},{"key":"10.1016\/j.clim.2024.110372_bb0105","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nmeth.1273","article-title":"Human protein factory for converting the transcriptome into an in vitro-expressed proteome","volume":"5","author":"Goshima","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.clim.2024.110372_bb0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1440-1827.1999.00875.x","article-title":"Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method","volume":"49","author":"Toda","year":"1999","journal-title":"Pathol. Int."},{"key":"10.1016\/j.clim.2024.110372_bb0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.clim.2024.110372_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","article-title":"The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody","volume":"49","author":"Nakashima","year":"2010","journal-title":"Rheumatol. (Oxf. Engl.)."},{"key":"10.1016\/j.clim.2024.110372_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2017.04.007","article-title":"The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies","volume":"127","author":"Tanizawa","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.clim.2024.110372_bb0130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/ni.1932","article-title":"IFI16 is an innate immune sensor for intracellular DNA","volume":"11","author":"Unterholzner","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.110372_bb0135","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3389\/fimmu.2018.01180","article-title":"The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: the dark side of sensing microbes","volume":"9","author":"Caneparo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110372_bb0140","first-page":"1262","article-title":"Anti-interferon-inducible protein 16 antibodies associate with digital gangrene in patients with scleroderma, arthritis","volume":"68","author":"McMahan","year":"2016","journal-title":"Rheumatol."},{"key":"10.1016\/j.clim.2024.110372_bb0145","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/rheumatology\/keq372","article-title":"Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis","volume":"50","author":"Costa","year":"2011","journal-title":"Rheumatol. (Oxf. Engl.)."},{"key":"10.1016\/j.clim.2024.110372_bb0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/acr.22632","article-title":"Association of antibodies to interferon-inducible Protein-16 with markers of more severe disease in primary Sjogren\u2019s syndrome","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2024.110372_bb0155","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/art.1780371117","article-title":"Interferon-gamma-inducible protein p16. A new target of antinuclear antibodies in patients with systemic lupus erythematosus","volume":"37","author":"Seelig","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110372_bb0160","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/art.22266","article-title":"A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16","volume":"54","author":"Mondini","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110372_bb0165","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1021\/bi981069a","article-title":"Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing","volume":"37","author":"Johnstone","year":"1998","journal-title":"Biochemistry."},{"key":"10.1016\/j.clim.2024.110372_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113036","article-title":"The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines","volume":"150","author":"Borucka","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2021","key":"10.1016\/j.clim.2024.110372_bb0175","first-page":"709","article-title":"Guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease","volume":"59","author":"Y. Kondoh, S. Makino, T. Ogura, T. Suda, H. Tomioka, H. Amano, M. Anraku, N. Enomoto, T. Fujii, T. Fujisawa, T. Gono, M. Harigai, H. Ichiyasu, Y. Inoue, T. Johkoh, H. Kameda, K. Kataoka, Y. Katsumata, Y. Kawaguchi, A. Kawakami, H. Kitamura, N. Kitamura, T. Koga, K. Kurasawa, Y. Nakamura, R. Nakashima, Y. Nishioka, O. Nishiyama, M. Okamoto, F. Sakai, S. Sakamoto, S. Sato, T. Shimizu, N. Takayanagi, R. Takei, T. Takemura, T. Takeuchi, Y. Toyoda, H. Yamada, H. Yamakawa, Y. Yamano, Y. Yamasaki, M. Kuwana, joint committee of Japanese Respiratory Society and Japan College of Rheumatology","year":"2020","journal-title":"Respir. Investig."},{"key":"10.1016\/j.clim.2024.110372_bb0180","article-title":"Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases","volume":"7","author":"Salonen","year":"2020","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.clim.2024.110372_bb0185","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01339-2016","article-title":"Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis","volume":"49","author":"Collard","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2024.110372_bb0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.rmed.2016.05.030","article-title":"Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease","volume":"117","author":"Kono","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.clim.2024.110372_bb0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00418-002-0485-0","article-title":"Expression of IFI 16 in epithelial cells and lymphoid tissues","volume":"119","author":"Wei","year":"2003","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.clim.2024.110372_bb0200","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110372_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063045","article-title":"Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding","volume":"8","author":"Gugliesi","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624004819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624004819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T15:33:05Z","timestamp":1729870385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624004819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"alternative-id":["S1521661624004819"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110372","relation":{},"ISSN":["1521-6616"],"issn-type":[{"type":"print","value":"1521-6616"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-interferon gamma-inducible protein 16 antibodies: Identification of a novel autoantigen in idiopathic interstitial pneumonia and its clinical characteristics based on a multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110372"}}